A detailed history of Pineridge Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pineridge Advisors LLC holds 941 shares of ABBV stock, worth $168,627. This represents 0.07% of its overall portfolio holdings.

Number of Shares
941
Previous 945 0.42%
Holding current value
$168,627
Previous $162 Million 14.64%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$163.84 - $199.33 $655 - $797
-4 Reduced 0.42%
941 $186 Million
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $4,953 - $5,784
32 Added 3.5%
945 $162 Million
Q1 2024

May 16, 2024

SELL
$159.82 - $182.1 $40,594 - $46,253
-254 Reduced 21.77%
913 $166 Million
Q4 2023

Mar 01, 2024

BUY
$137.6 - $154.97 $160,579 - $180,849
1,167 New
1,167 $181 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pineridge Advisors LLC Portfolio

Follow Pineridge Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pineridge Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pineridge Advisors LLC with notifications on news.